Formation Biologics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Formation Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2817
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Formation Biologics Inc (Formation Biologics), formerly AvidBiologics Inc is a clinical stage pharmaceutical company that develops biologics and antibody-drug conjugates (ADCs) with selective anti-tumor properties for the treatment of cancer and rare diseases. The company’s pipeline product portfolio includes AVID100, anti-EGFR antibody-drug conjugate for treating solid tumors; AVID200, Isoform-selective TGF- beta inhibitor neutralizing promotion of cancer metastasis, negative effects on hematopoiesis and cardiac toxicity; AVID300; and AVID400. Its ADCs prevents the inadvertent destruction of normal tissues, unlike traditional chemotherapies, which leads to safe and effective anti-cancer treatment. It also offers preclinical and early-stage clinical development of its proprietary compounds. Formation Biologics is headquartered in Montreal, Quebec, Canada.

Formation Biologics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Formation Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Formation Biologics Raises Funds through Series B Venture Financing 10
Formation Biologics to Raise USD1 Million in Venture Financing 11
AvidBiologics Raises Funds through Venture Financing 12
Formation Biologics Raises Funds through Seed Financing 13
Partnerships 14
AvidBiologics Enters Into Co-Development Agreement With National Research Council of Canada 14
Formation Biologics Inc – Key Competitors 15
Formation Biologics Inc – Key Employees 16
Formation Biologics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
May 15, 2017: Formation Biologics Announces Appointment of Dr. Anthony Tolcher to its Board of Directors 18
Product News 19
05/15/2017: Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID100 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Formation Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Formation Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Formation Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Formation Biologics Raises Funds through Series B Venture Financing 10
Formation Biologics to Raise USD1 Million in Venture Financing 11
AvidBiologics Raises Funds through Venture Financing 12
Formation Biologics Raises Funds through Seed Financing 13
AvidBiologics Enters Into Co-Development Agreement With National Research Council of Canada 14
Formation Biologics Inc, Key Competitors 15
Formation Biologics Inc, Key Employees 16
Formation Biologics Inc, Other Locations 17

List of Figures
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Formation Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Formation Biologics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Provogue (India) Limited (PROVOGE):企業の財務・戦略的SWOT分析
    Provogue (India) Limited (PROVOGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ecopetrol SA (ECOPETROL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ecopetrol SA (Ecopetrol) is a vertically integrated oil and gas company that carries out exploration, development and production of oil and gas. It is also involved in refining of crude oil to produce petroleum products, besides transportation services. Ecopetrol owns and operates refineries …
  • Amplifon SpA (AMP):医療機器:M&Aディール及び事業提携情報
    Summary Amplifon SpA (Amplifon) is a medical device company, which provides customized hearing solutions and services. It distributes hearing aids and other audio and telephony solutions. The company also offers related services such as audiological assessment, education, counseling, customization a …
  • Nufarm Limited:企業の戦略・SWOT・財務情報
    Nufarm Limited - Strategy, SWOT and Corporate Finance Report Summary Nufarm Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kopin Corp (KOPN):企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • Cardiva Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • Kobayashi Pharmaceutical Co Ltd (4967):医療機器:M&Aディール及び事業提携情報
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • Associated Milk Producers Inc.:企業の戦略・SWOT・財務情報
    Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report Summary Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company provides services such as consultancy services, administration, financing, development, and management of wind farms. It also of …
  • Investitionsbank Berlin:企業の戦略・SWOT・財務分析
    Investitionsbank Berlin - Strategy, SWOT and Corporate Finance Report Summary Investitionsbank Berlin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Astronics AeroSat Corporation:企業の戦略・SWOT・財務情報
    Astronics AeroSat Corporation - Strategy, SWOT and Corporate Finance Report Summary Astronics AeroSat Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tiziana Life Sciences Plc (TILS):製薬・医療:M&Aディール及び事業提携情報
    Summary Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The company’s lead product candidate, TZLS-201, intended for the treatment of thymic carcin …
  • Campofrio Food Group, S.A.:戦略・SWOT・企業財務分析
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • San Miguel Brewery Hong Kong Ltd.:企業の戦略・SWOT・財務情報
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Compagnie d’Entreprises CFE SA:企業の戦略・SWOT・財務情報
    Compagnie d'Entreprises CFE SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie d'Entreprises CFE SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gene Techno Science Co Ltd (4584):企業の財務・戦略的SWOT分析
    Summary Gene Techno Science Co Ltd (GTS) develops and markets drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological, biosimilar and regenerative medicine in the therapy areas of renal disease, immunological, oncology, ophthalmic, and bone related di …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆